A life-extending treatment for advanced cervical cancer will be made available to hundreds of NHS patients from today. The immunotherapy drug pembrolizumab (Keytruda®) is the first new addition to NHS treatment for incurable cervical cancer for 14 years. Around 400 people are expected to benefit from the treatment over the next three years after NHS […]
Read More on the NHS website.